Gadoxetic acid
|
WikiDoc Resources for Gadoxetic acid |
|
Articles |
|---|
|
Most recent articles on Gadoxetic acid Most cited articles on Gadoxetic acid |
|
Media |
|
Powerpoint slides on Gadoxetic acid |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Gadoxetic acid at Clinical Trials.gov Trial results on Gadoxetic acid Clinical Trials on Gadoxetic acid at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Gadoxetic acid NICE Guidance on Gadoxetic acid
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Gadoxetic acid Discussion groups on Gadoxetic acid Patient Handouts on Gadoxetic acid Directions to Hospitals Treating Gadoxetic acid Risk calculators and risk factors for Gadoxetic acid
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Gadoxetic acid |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1]
References
- ↑ "Eovist - Homepage". Retrieved 2009-03-22.
